- J. B. Fu, Y. Zhang, Y. X. Wang, H. N. Zhang, J. Liu, J. Tang, Q. X. Yang, H. C. Sun, W. Q. Qiu, Y. H. Ma, Z. R. Li, M. Y. Zheng, F. Zhu*. Optimization of metabolomic data processing using NOREVA. Nature Protocols (当年影响因子: 17.021, 生物一区 TOP 期刊). 17(1): 129-151 (2022). PMID: 34952956.
杂志精选论文:
科技媒体及新闻报道:
- Beijing Academy of AI. Dec 31th, 2021.
- Chowdera.com. Dec 31th, 2021.
- CPS@ZJU. Dec 30th, 2021.
- Chinese ZhiHu. Dec 31th, 2021.
- DrugAI. Dec 31th, 2021.
- eBiotrade. Jan 1th, 2022.
- ECHEMI.com. Jan 27th, 2022.
- Gene Online. Jan 1th, 2022.
- India Education Diary. Jan 28th, 2022.
- Mirage News. Jan 27th, 2022.
- Neurons AI. Jan 27th, 2022.
- NSF@Zhejiang. Jan 24th, 2022.
- Tencent Cloud. Jan 1th, 2022.
- ZJU Newsroom. Jan 26th, 2022.
- Zhejiang University. Dec 30th, 2021.
- Y. X. Wang, S. Zhang, F. C. Li, Y. Zhou, Y. Zhang, Z. W. Wang, R. Y. Zhang, J. Zhu, Y. X. Ren, Y. Tan, C. Qin, Y. H. Li, X. X. Li, Y. Z. Chen*, F. Zhu*. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Research (当年影响因子: 16.971, 生物一区 TOP 期刊). 48(D1): 1031-1041 (2020). PMID: 31691823.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.13% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.15% in 2021.
科技媒体及新闻报道:
- Q. X. Yang, Y. X. Wang, Y. Zhang, F. C. Li, W. Q. Xia, Y. Zhou, Y. Q. Qiu, H. L. Li, F. Zhu*. NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data. Nucleic Acids Research (当年影响因子: 16.971, 生物一区 TOP 期刊). 48(W1): 436-448 (2020). PMID: 32324219.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 1.60% in 2022.
科技媒体及新闻报道:
- J. Y. Yin, W. Sun, F. C. Li, J. J. Hong, X. X. Li, Y. Zhou, Y. J. Lu, M. Z. Liu, X. Zhang, N. Chen, X. P. Jin, J. Xue, S. Zeng*, L. S. Yu*, F. Zhu*. VARIDT 1.0: variability of drug transporter database. Nucleic Acids Research (当年影响因子: 16.971, 生物一区 TOP 期刊). 48(D1): 1042-1050 (2020). PMID: 31495872.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.96% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.33% in 2021.
科技媒体及新闻报道:
- T. T. Fu, F. C. Li, Y. Zhang, J. Y. Yin, W. Q. Qiu, X. D. Li, X. G. Liu, W. W. Xin, C. Z. Wang, L. S. Yu, J. Q. Gao, Q. C. Zheng*, S. Zeng*, F. Zhu*. VARIDT 2.0: structural variability of drug transporter. Nucleic Acids Research (当年影响因子: 19.160, 生物一区 TOP 期刊). 50(D1): 1417-1431 (2022). PMID: 34747471.
科技媒体及新闻报道:
- X. N. Wang, F. C. Li, W. Q. Qiu, B. B. Xu, Y. L. Li, X. C. Lian, H. Y. Yu, Z. Zhang, J. X. Wang, Z. R. Li, W. W. Xue*, F. Zhu*. SYNBIP: synthetic binding proteins for research, diagnosis and therapy. Nucleic Acids Research (当年影响因子: 19.160, 生物一区 TOP 期刊). 50(D1): 560-570 (2022). PMID: 34664670.
科技媒体及新闻报道:
- J. Y. Yin, F. C. Li, Y. Zhou, M. J. Mou, Y. J. Lu, K. L. Chen, J. Xue, Y. C. Luo, J. B. Fu, X. He, J. Q. Gao, S. Zeng*, L. S. Yu*, F. Zhu*. INTEDE: interactome of drug-metabolizing enzymes. Nucleic Acids Research (当年影响因子: 19.160, 生物一区 TOP 期刊). 49(D1): 1233-1243 (2021). PMID: 33045737.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 1.12% in 2022.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 1.12% in 2022.
科技媒体及新闻报道:
- J. Tang, X. L. Wu, M. J. Mou, C. Wang, L. D. Wang, F. C. Li, M. Y. Guo, J. Y. Yin, W. Q. Xie, X. N. Wang, Y. X. Wang, Y. B. Ding*, W. W. Xue*, F. Zhu*. GIMICA: host genetic and immune factors shaping human microbiota. Nucleic Acids Research (当年影响因子: 19.160, 生物一区 TOP 期刊). 49(D1): 715-722 (2021). PMID: 33045729.
科技媒体及新闻报道:
- Y. H. Li, C. Y. Yu, X. X. Li, P. Zhang, J. Tang, Q. X. Yang, T. T. Fu, X. Y. Zhang, X. J. Cui, G. Tu, Y. Zhang, S. Li, F. Y. Yang, Q. Sun, C. Qin, X. Zeng, Z. Chen, Y. Z. Chen*, F. Zhu*. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Research (当年影响因子: 11.561, 生物一区 TOP 期刊). 46(D1): 1121-1127 (2018). PMID: 29140520.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.21% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.15% in 2021.
- The Percentile in Subject Area shown in InCites™ was 0.14% in 2020.
- The Percentile in Subject Area shown in InCites™ was 0.16% in 2019.
领域内专家评论:
- Introduced by OMICTOOLS as "useful for facilitating patient focused research, discovery and clinical investigations of the targeted therapeutics".
- B. Li, J. Tang, Q. X. Yang, S. Li, X. J. Cui, Y. H. Li, Y. Z. Chen, W. W. Xue, X. F. Li, F. Zhu*. NOREVA: normalization and evaluation of MS-based metabolomics data. Nucleic Acids Research (当年影响因子: 10.162, 生物一区 TOP 期刊). 45(W1): 162-170 (2017). PMID: 28525573.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.77% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.71% in 2021.
- The Percentile in Subject Area shown in InCites™ was 0.75% in 2020.
- The Percentile in Subject Area shown in InCites™ was 1.27% in 2019.
- The Percentile in Subject Area shown in InCites™ was 2.98% in 2018.
领域内专家评论:
- Introduced by OMICTOOLS as "provided valuable guidance to the selection of suitable algorithm in metabolomics".
- Discussed in StackExchange as "works fine" and "corrections for batches without QC options".
- F. Zhu, Z. Shi, C. Qin, L. Tao, X. Liu, F. Xu, L. Zhang, Y. Song, X. H. Liu, J. X. Zhang, B. C. Han, P. Zhang, Y. Z. Chen*. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Research (当年影响因子: 8.026, 生物一区 TOP 期刊). 40(D1): 1128-1136 (2012). PMID: 21948793.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.77% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.69% in 2021.
- The Percentile in Subject Area shown in InCites™ was 0.66% in 2020.
- The Percentile in Subject Area shown in InCites™ was 0.60% in 2019.
- The Percentile in Subject Area shown in InCites™ was 0.62% in 2018.
- The Percentile in Subject Area shown in InCites™ was 0.31% in 2017.
- F. Zhu, B. C. Han, P. Kumar, X. H. Liu, X. H. Ma, X. N. Wei, L. Huang, Y. F. Guo, L. Y. Han, C. J. Zheng, Y. Z. Chen*. Update of TTD: therapeutic target database. Nucleic Acids Research (当年影响因子: 7.479, 生物一区 TOP 期刊). 38(D1): 787-791 (2010). PMID: 19933260.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 2.95% in 2017.
- F. Zhu, C. Qin, L. Tao, X. Liu, Z. Shi, X. H. Ma, J. Jia, Y. Tan, C. Cui, J. S. Lin, C. Y. Tan, Y. Y. Jiang*, Y. Z. Chen*. Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting. Proceedings of the National Academy of Sciences of the United States of America (当年影响因子: 9.432, 综合性一区 TOP 期刊). 108(31): 12943-12948 (2011). PMID: 21768386.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.95% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.98% in 2021.
- The Percentile in Subject Area shown in InCites™ was 0.93% in 2020.
- The Percentile in Subject Area shown in InCites™ was 0.94% in 2019.
- The Percentile in Subject Area shown in InCites™ was 1.16% in 2018.
- The Percentile in Subject Area shown in InCites™ was 1.91% in 2017.
领域内专家评论:
科技媒体及新闻报道:
- NEWS MEDICAL. Sep 8th, 2011.
- Medical News Today (MNT). Sep 7th, 2011.
- mediLexicon.com. Sep 7th, 2011.
- BrightSurf.com. Sep 7th, 2011.
- SCIENCE CODEX. Sep 6th, 2011.
- Sciencenewsline biology. Sep 6th, 2011.
- MedicalXpress. Sep 6th, 2011.
- FirstScience News. Sep 6th, 2011.
- Labspaces.net. Sep 6th, 2011.
- EurekAlert. Sep 6th, 2011.
- eBioNews. Sep 1st, 2011.
- ScienceDaily. Aug 31st, 2011.
- HealthCanal.com. Aug 31st, 2011.
- News Ecology. Aug 31st, 2011.
- Y. H. Li, X. X. Li, J. J. Hong, Y. X. Wang, J. B. Fu, H. Yang, C. Y. Yu, F. C. Li, J. Hu, W. W. Xue, Y. Y. Jiang, Y. Z. Chen*, F. Zhu*. Clinical trials, progression-speed differentiating features, and swiftness rule of the innovative targets of first-in-class drugs. Briefings in Bioinformatics (当年影响因子: 11.622, 生物一区 TOP 期刊). 21(2): 649-662 (2020). PMID: 30689717.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.49% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.09% in 2021.
- J. Tang, J. B. Fu, Y. X. Wang, B. Li, Y. H. Li, Q. X. Yang, X. J. Cui, J. J. Hong, X. F. Li, Y. Z. Chen, W. W. Xue, F. Zhu*. ANPELA: analysis and performance-assessment of the label-free quantification workflow for metaproteomic studies. Briefings in Bioinformatics (当年影响因子: 11.622, 生物一区 TOP 期刊). 21(2): 621-636 (2020). PMID: 30649171.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.20% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.05% in 2021.
- Q. X. Yang, B. Li, J. Tang, X. J. Cui, Y. X. Wang, X. F. Li, J. Hu, Y. Z. Chen, W. W. Xue, Y. Lou, Y. Q. Qiu*, F. Zhu*. Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data. Briefings in Bioinformatics (当年影响因子: 11.622, 生物一区 TOP 期刊). 21(3): 1058-1068 (2020). PMID: 31157371.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.56% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.19% in 2021.
- J. J. Hong, Y. C. Luo, M. J. Mou, J. B. Fu, Y. Zhang, W. W. Xue, T. Xie, L. Tao*, Y. Lou*, F. Zhu*. Convolutional neural network-based annotation of bacterial type IV secretion system effectors with enhanced accuracy and reduced false discovery. Briefings in Bioinformatics (当年影响因子: 11.622, 生物一区 TOP 期刊). 21(5): 1825-1836 (2020). PMID: 31860715.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 1.18% in 2022.
- Z. J. Han, W. W. Xue, L. Tao, Y. Lou, Y. Q. Qiu*, F. Zhu*. Genome-wide identification and analysis of the eQTL lncRNAs in multiple sclerosis based on RNA-seq data. Briefings in Bioinformatics (当年影响因子: 11.622, 生物一区 TOP 期刊). 21(3): 1023-1037 (2020). PMID: 31323688.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 2.22% in 2022.
- J. J. Hong, Y. C. Luo, Y. Zhang, J. B. Ying, W. W. Xue, T. Xie, L. Tao*, F. Zhu*. Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning. Briefings in Bioinformatics (当年影响因子: 11.622, 生物一区 TOP 期刊). 21(4): 1437-1447 (2020). PMID: 31504150.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.94% in 2022.
- Q. X. Yang, J. J. Hong, Y. Li, W. W. Xue, S. Li*, H. Yang*, F. Zhu*. A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies. Briefings in Bioinformatics (当年影响因子: 11.622, 生物一区 TOP 期刊). 21(6): 2142-2152 (2020). PMID: 31776543.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 2.69% in 2022.
- F. C. Li, Y. Zhou, Y. Zhang, J. Y. Yin, Y. Q. Qiu, J. Q. Gao, F. Zhu*. POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability. Briefings in Bioinformatics (当年影响因子: 13.994, 生物一区 TOP 期刊). 23(2): bbac040 (2022). PMID: 35183059.
- F. C. Li, J. Y. Yin, M. K. Lu, Q. X. Yang, Z. Y. Zeng, B. Zhang, Z. R. Li, Y. Q. Qiu, H. B. Dai, Y. Z. Chen*, F. Zhu*. ConSIG: consistent discovery of molecular signature from OMIC data. Briefings in Bioinformatics (当年影响因子: 13.994, 生物一区 TOP 期刊). doi:10.1093/bib/bbac253 (2022). PMID: 35758241.
- S. Zhang, K. Amahong, C. Y. Zhang, F. C. Li, J. Q. Gao, Y. Q. Qiu*, F. Zhu*. RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection. Briefings in Bioinformatics (当年影响因子: 13.994, 生物一区 TOP 期刊). 23(1): bbab397 (2022). PMID: 34585235.
- S. Zhang, Y. Zhou, Y. N. Wang, Z. W. Wang, Q. T. Xiao, Y. Zhang, Y. Lou, Y. Q. Qiu*, F. Zhu*. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years. Briefings in Bioinformatics (当年影响因子: 13.994, 生物一区 TOP 期刊). 22(2): 1860-1883 (2021). PMID: 32249290.
- J. B. Fu, Y. Zhang, J. Liu, X. C. Lian, J. Tang, F. Zhu*. Pharmacometabonomics: data processing and statistical analysis. Briefings in Bioinformatics (当年影响因子: 13.994, 生物一区 TOP 期刊). 22(5): bbab138 (2021). PMID: 33866355.
- J. Tang, M. J. Mou, Y. X. Wang, Y. C. Luo, F. Zhu*. MetaFS: performance assessment for biomarker discovery in metaproteomics. Briefings in Bioinformatics (当年影响因子: 13.994, 生物一区 TOP 期刊). 22(3): bbaa105 (2021). PMID: 32510556.
- J. Tang, Y. X. Wang, J. B. Fu, Y. Zhou, Y. C. Luo, Y. Zhang, B. Li, Q. X. Yang, W. W. Xue, Y. Lou, Y. Q. Qiu*, F. Zhu*. A critical assessment of the feature selection methods used for biomarker discovery in current metaproteomic studies. Briefings in Bioinformatics (当年影响因子: 11.622, 生物一区 TOP 期刊). 21(4): 1378-1390 (2020). PMID: 31197323.
- S. Zhang, F. Zhu*. Comment on microRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19. Drugs (当年影响因子: 11.431, 医学二区 TOP 期刊). 81(14): 1691-1692 (2021). PMID: 34453690.
- Y. X. Wang, F. C. Li, Y, Zhang, Y. Zhou, Y. Tan, Y. Z. Chen*, F. Zhu*. Databases for the targeted COVID-19 therapeutics. British Journal of Pharmacology (当年影响因子: 7.730, 医学二区 TOP 期刊). 177(21): 4999-5001 (2020). PMID: 32845521.
- J. Y. Yin, X. X. Li, F. C. Li, Y. J. Lu, S. Zeng*, F. Zhu*. Identification of the key target profiles underlying the drugs of narrow therapeutic index for treating cancer and cardiovascular disease. Computational and Structural Biotechnology Journal (当年影响因子: 7.271, 生物二区期刊). 19: 2318-2328 (2021). PMID: 33995923.
- J. Tang, Y. X. Wang, Y. C. Luo, J. B. Fu, Y. Zhang, Y. Li, Z. Y. Xiao, Y. Lou, Y. Q. Qiu*, F. Zhu*. Computational advances of tumor marker selection and sample classification in cancer proteomics. Computational and Structural Biotechnology Journal (当年影响因子: 6.018, 生物二区 TOP 期刊). 18: 2012-2025 (2020). PMID: 32802273.
- T. T. Fu, G. Tu, M. Ping, G. X. Zheng, F. Y. Yang, J. Y. Yang, Y. Zhang, X. J. Yao, W. W. Xue*, F. Zhu*. Subtype selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. Acta Pharmacologica Sinica (当年影响因子: 6.150, 医学一区 TOP 期刊). 42(8): 1354-1367 (2021). PMID: 33122823.
- J. Tang, J. B. Fu, Y. X. Wang, Y. C. Luo, Q. X. Yang, B. Li, G. Tu, J. J. Hong, X. J. Cui, Y. Z. Chen, L. X. Yao, W. W. Xue, F. Zhu*. Simultaneous improvement in the precision, accuracy and robustness of label-free proteome quantification by optimizing data manipulation chains. Molecular & Cellular Proteomics (当年影响因子: 5.236, 生物二区 TOP 期刊). 18(8): 1683-1699 (2019). PMID: 31097671.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 1.12% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.81% in 2021.
- The Percentile in Subject Area shown in InCites™ was 0.57% in 2020.
- F. C. Li, Y. Zhou, X. Y. Zhang, J. Tang, Q. X. Yang, Y. Zhang, Y. C. Luo, J. Hu*, W. W. Xue, Y. Q. Qiu, Q. J. He, B. Yang, F. Zhu*. SSizer: determining the sample sufficiency for comparative biological study. Journal of Molecular Biology (当年影响因子: 5.067, 生物二区 TOP 期刊). 432(11): 3411-3421 (2020). PMID: 32044343.
- W. Q. Xia, L. Y. Zheng, J. B. Fang, F. C. Li, Y. Zhou, Z. Y. Zeng, B. Zhang, Z. R. Li, H. L. Li*, F. Zhu*. PFmulDL: a novel strategy enabling multi-class and multi-label protein function annotation by integrating diverse deep learning methods. Computers in Biology and Medicine (当年影响因子: 6.698, 工程技术二区期刊). 145: 105465 (2022). PMID: 35366467.
- Y. Zhang, J. B. Ying, J. J. Hong, F. C. Li, T. T. Fu, F. Y. Yang, G. X. Zheng, X. J. Yao, Y. Lou, Y. Q. Qiu, W. W. Xue*, F. Zhu*. How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from Trichostatin A enantiomers based on molecular dynamics. ACS Chemical Neuroscience (当年影响因子: 4.211, 化学二区 TOP 期刊). 10(5): 2467-2480 (2019). PMID: 30784262.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 1.85% in 2022.
- The Percentile in Subject Area shown in InCites™ was 1.19% in 2021.
- The Percentile in Subject Area shown in InCites™ was 0.74% in 2020.
封面论文:
- W. W. Xue, F. Y. Yang, P. P. Wang, G. X. Zheng, Y. Z. Chen, X. J. Yao, F. Zhu*. What contributes to serotonin-norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by MD simulation. ACS Chemical Neuroscience (当年影响因子: 4.211, 化学二区 TOP 期刊). 9(5): 1128-1140 (2018). PMID: 29300091.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 0.18% in 2022.
- The Percentile in Subject Area shown in InCites™ was 0.14% in 2021.
- The Percentile in Subject Area shown in InCites™ was 0.21% in 2020.
- The Percentile in Subject Area shown in InCites™ was 0.29% in 2019.
- P. P. Wang, X. Y. Zhang, T. T. Fu, S. Li, B. Li, W. W. Xue*, X. J. Yao, Y. Z. Chen, F. Zhu*. Differentiating physicochemical properties between addictive and nonaddictive ADHD drugs revealed by molecular dynamics simulation studies. ACS Chemical Neuroscience (当年影响因子: 4.348, 化学二区 TOP 期刊). 8(6): 1416-1428 (2017). PMID: 28557437.
ESI高被引或扩展高被引论文:
- The Percentile in Subject Area shown in InCites™ was 2.17% in 2022.
- The Percentile in Subject Area shown in InCites™ was 1.48% in 2021.
- The Percentile in Subject Area shown in InCites™ was 1.80% in 2020.
- The Percentile in Subject Area shown in InCites™ was 1.32% in 2019.
- F. Y. Yang, G. X. Zheng, T. T. Fu, X. F. Li, G. Tu, Y. H. Li, X. J. Yao, W. W. Xue*, F. Zhu*. Prediction of binding mode and resistance profile for dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase associated ribonuclease H. Physical Chemistry Chemical Physics (当年影响因子: 4.123, 化学二区 TOP 期刊). 20(37): 23873-23884 (2018). PMID: 29947629.
封底论文:
- W. W. Xue, T. T. Fu, S. Z. Deng, F. Y. Yang, J. Y. Yang, F. Zhu*. Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram. ACS Chemical Neuroscience (当年影响因子: 5.780, 医学二区期刊). 13(3): 340-351 (2022). PMID: 35041375.
- F. Zhu, L. Y. Han, C. J. Zheng, B. Xie, M. T. Tammi, S. Y. Yang, Y. Q. Wei, Y. Z. Chen*. What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical and system profiles of successful targets. Journal of Pharmacology and Experimental Therapeutics (当年影响因子: 3.867, 医学二区 TOP 期刊). 330(1): 304-315 (2009). PMID: 19357322.
所构建方法的临床或实验验证:
- Pasireotide targeting Somatostatin receptor 1 was approved by FDA in 2011.
- Fingolimod targeting S1P receptor was approved by FDA in 2010.
- Ecallantide targeting Plasma Kallikrein was approved by FDA in 2009.
Cinryze targeting C1 esterase was approved by FDA in 2009.
Icatibant targeting BK-2 receptor was approved by FDA in 2008.
Plerixafor targeting CXCR4 was approved by FDA in 2008.
Q. X. Yang, Y. X. Wang, F. C. Li, S. Zhang, Y. C. Luo, Y. Li, J. Tang, B. Li, Y. Z. Chen, W. W. Xue, F. Zhu*. Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility. CNS Neuroscience & Therapeutics (当年影响因子: 3.394, 医学二区期刊). 25(9): 1054-1063 (2019). PMID: 31350824.
封面论文:
Z. J. Han, W. W. Xue, L. Tao, F. Zhu*. Identification of novel immune-relevant drug target genes for alzheimer's disease by combining ontology inference with network analysis. CNS Neuroscience & Therapeutics (当年影响因子: 3.495, 医学二区期刊). 24(12): 1253-1263 (2018). PMID: 30106219.
奖励与荣誉:
- Wiley Top Cited Paper Award (2020).
封面论文:
|